Sicagen India Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Sicagen India Ltd. on BSE

Search Inside the pdf :

07 Aug 2025

Board Meeting

Sicagen India Ltd - 533014 - Board Meeting Intimation for Consideration And Approval Of The Un-Audited …

BSE India

Sicagen India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve the Un-audited Financial Results (both Standalone & Consolidated) of the Company for the Quarter ended 30th June, 2025.

pdf

Sicagen India Ltd.

09 Jul 2025, 04:50PM

Company Update

Sicagen India Ltd - 533014 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018 for the quarter ended 30th June, 2025.

pdf

Sicagen India Ltd.

27 Jun 2025

SAST

Sicagen India Ltd - 533014 - Closure of Trading Window

BSE India

Intimation of trading window closure for the quarter ended 30th June, 2025.

pdf

Sicagen India Ltd.

06 Jun 2025

Company Update

Sicagen India Ltd - 533014 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Notice to shareholders regarding transfer of equity shares to IEPF through newspaper publication dated 05.06.2025 in Business Standard & Makkal Kural. Copies of both the newspaper publication are enclosed herewith.

pdf

Sicagen India Ltd.

27 May 2025

Company Update

Sicagen India Ltd - 533014 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Annual Secretarial Compliance Report for the year ended 31st March, 2025.

pdf

Sicagen India Ltd.

12 May 2025

Company Update

Sicagen India Ltd - 533014 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Appointment/Re-appointment of Internal Auditor, Cost Auditor & Secretarial Auditor.

pdf

Sicagen India Ltd.

12 May 2025

Company Update

Sicagen India Ltd - 533014 - Equity Dividend For The FY 2024-25.

BSE India

Declaration of equity dividend for the FY 2024-25.

pdf

Sicagen India Ltd.

12 May 2025

Result

Sicagen India Ltd - 533014 - Audited Financial Results For The Quarter & Year Ended 31.03.2025.

BSE India

Audited Financial Results (both Standalone & Consolidated) of the Company for the quarter & year ended on 31.03.2025 together with the Auditors Report thereon.

pdf

Sicagen India Ltd.

12 May 2025

Board Meeting

Sicagen India Ltd - 533014 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

In the meeting of Board of Directors of the Company held on 12.05.2025 i.e. today, the Board has inter-alia considered and approved the Audited Financial Results (both Standalone & Consolidated) of the Company for the Quarter and year ended 31st March, 2025 together with the Auditors Report thereon. The Board has also recommended 10% Equity Dividend (One rupee per share) on Equity Capital of the Company for the Financial Year 2024-25.

pdf

Sicagen India Ltd.

02 May 2025

Board Meeting

Sicagen India Ltd - 533014 - Board Meeting Intimation for Consideration And Approval Of The Audited …

BSE India

Sicagen India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 ,inter alia, to consider and approve the Audited Financial Results (both Standalone & Consolidated) of the Company for the Quarter & year ended 31st March, 2025 and recommend the Equity Dividend (If Any) for the Financial Year 2024-25.

pdf

Is Sicagen India Ltd. worth buying?

91 Votes:

Buy 89.01%

Sell 7.69%

Hold 3.3%